+1 800 987 6007

2 September, 2020, by clincapture-client

ClinCapture is excited to announce Captivate 3.4 with new features that improve your experience. We’ve enhanced the system and added additional tools.

Here is a breakdown of the changes:

Build
New VAS Scale
Printable annotated case report forms (CRFs)
Customizable date/time format
Ability for users to fully build and configure patient surveys themselves within ePRO

Live
Data import via CSV file
PHI settings based on roles
Query owner export
Improved email alert notifications
Calendar enhancements

Advanced Reporting
Report data by event or in aggregate
Added Log base 10 function
View and test reporting in the test environment

Additional features
Subject calendar visit windows
Automatic triggers to send ePRO surveys

To learn more about our latest features and enhancements, contact your Account Manager at ClinCapture.

Up Next

  • Are accelerated trials the new normal?

    Over the past several months, clinical trials have moved at a rapid pace to find viable treatments for COVID-19. The Food and Drug Administration (FDA) created an emergency program that “uses every available method to move new treatments to patients as quickly as possible.” As of July 31, more than 570 drug development programs were in planning stages, more than 270 trials were reviewed by the
    Read more +
  • 1 September, 2020

    Meet the Team: Scott Weidley

    In San Francisco, as office spaces remain closed, workers are busy keeping up with day-to-day business out of their homes. That includes ClinCapture CEO Scott Weidley. Sitting in his home office surrounded by vintage guitars, Weidley checks-in with employees through video calls and emails. “I am very proud of what the team has accomplished while working remotely, but I am excited for the day
    Read more +
  • 16 March, 2020

    Clinical Research for COVID-19

    With the pandemic of COVID-19, efforts to speed up treatments and develop a vaccine are increasing dramatically. Many companies have been repurposing antivirals while others are pursuing a more high-tech approach. With recent findings from Clover Biopharmaceuticals, COVID-19 is variegated with a protein aptly called ‘Spike’ (S) protein, allowing the virus to burrow into the cells of humans, ma
    Read more +

Why wait? Power up
with ClinCapture today!

Sign Up For a Demo